Plasma perfluoroalkyl and polyfluoroalkyl substances concentration and menstrual cycle characteristics in preconception women
Authors: Zhou, W; Zhang, L; Tong, C; Fang, F; Zhao, S; Tian, Y; Tao, Y; Zhang, J; Shanghai Birth Cohort Study
Environmental Health Perspectives 125:067012.
HERO ID: 3859799
BACKGROUND: Perfluoroalkyl and polyfluoroalkyl substances (PFASs) are persistent synthetic . . .
BACKGROUND: Perfluoroalkyl and polyfluoroalkyl substances (PFASs) are persistent synthetic chemicals that are widely used in industrial applications and often detectable in humans. In rats, PFASs can interfere with the estrous cycle. In humans, menstruation has been viewed as a proxy of female fecundity, and periodic menstruation plays a critical role in endometrial sloughing in the absence of pregnancy and in preparing for embryo implantation.
OBJECTIVES: We investigated the association between PFAS exposure and menstrual cycle characteristics in women who plan to become pregnant.
METHODS: Plasma level of 10 PFASs was measured in 950 women who were attempting to become pregnant and recruited in two preconception care clinics in Shanghai, China, from August 2013 to April 2015. Information on menstrual cycle characteristics was collected by questionnaires. Associations between PFAS levels and menstrual cycle regularity, length, and bleeding volume were examined using multiple logistic regression models.
RESULTS: Pre-pregnant women with higher levels of log-transformed perfluorooctanate (PFOA), perfluorooctane sulfonate (PFOS), perfluorononanoic acid (PFNA), and perfluorohexanesulfonate (PFHxS) had increased odds of self-reported history of irregular menstrual cycle [ (95% CI: 1.08, 2.15); (95% CI: 0.98, 1.70); (95% CI: 1.03, 2.07); (95% CI: 1.17, 2.77)] and long menstrual cycle [ (95% CI: 1.06, 2.10); (95% CI: 1.02, 1.75); (95% CI: 1.05, 2.11); (95% CI: 1.13, 2.65)]. Log-transformed PFOA, PFOS, PFNA. and PFHxS levels were negatively associated with self-reported history of menorrhagia [ (95% CI: 0.21, 0.65); (95% CI: 0.37, 0.90); (95% CI: 0.26, 0.86); (95% CI: 0.06, 0.36)].
CONCLUSIONS: Certain PFASs are associated with abnormal menstruation in humans. https://doi.org/10.1289/EHP1203.